Laryngeal or throat cancer in its early stages does not usually present symptoms, unless it involves the vocal cords and produces hoarseness in the patient.
The most common type of laryngeal cancer originates from a precancerous lesion (dysplasia) that when discovered in its early stages can be treated with a good chance of success.
It is one of the most frequent types of head and neck cancer. The chances of 5-year survival of a patient with laryngeal cancer depend on the part of the larynx where the cancer occurs and the stage of the disease. They range from approximately 90% in early stages to 32% in very advanced stages. The main risk factors for this type of cancer are tobacco and alcohol consumption. The treatment options offered by conventional medicine range from radiotherapy, surgery, chemotherapy, or a combination of these. The chances of success of these treatments also depend on the stage of the cancer and carry with them different side effects. The treatment options and effectiveness for patients with advanced cancer are still few and are mostly aimed at keeping the disease under control for as long as possible and relieving symptoms.
Escozul™ can be administered in conjunction with any conventional treatment. Escozul™ seeks to work not only on the cancer but also on the patient's quality of life. Its analgesic and anti-inflammatory effects help to improve the quality of life in about 65 to 75% of the patients treated. Through its antitumor effect, depending on the stage, one of the following results is expected: to slow down the progression of the disease, to stop tumor growth, to reduce the size of lesions or to eliminate tumor lesions.
It is important to point out that Escozul™ is not considered a cure for cancer, it is a natural medicine that converts this deadly disease into a controlled chronic one, also offering quality of life.
Results in different cases
Laryngeal cancer III lymph node metastasis Patient: Mario Age: 47 years Country: Mexico
Laryngeal cancer EC III (well differentiated invasive squamous cell carcinoma in left vocal cord) with invasion to cricoid cartilage and involvement of pretracheal and paratracheal lymph nodes.Read more
Patient with laryngeal cancer manages to overcome the disease.
EC III laryngeal cancer (well-differentiated invasive squamous cell carcinoma in left vocal cord) with invasion of cricoid cartilage and involvement of pretracheal and paratracheal lymph nodes.
Patient's condition before starting treatment:
- - Throat and ear pain
- - reflux
- - occasional vomiting
- - irregular rest
- - loss of voice
The case was evaluated by analyzing the type of cancer, its stage, aggressiveness, treatments applied and response. The physical and psychological condition of the patient was also taken into account. With this evaluation we explained to the family the possible results of the use of Escozul™. Given the extent of the disease we hoped to at least help control its growth and give Mario a better chance of survival.
He was started on Escozul™ in May 2015. At this time the only solution the doctors proposed to him was to remove the larynx, which was rejected by the patient. He started chemotherapy and radiotherapy at the beginning of July.
It is important to remember that Escozul™ is a natural product that has the capacity to eliminate tumor cells, without this meaning that it is a cure for cancer. Its ability to inhibit malignant cell growth allows it to be used as a disease controller and the work approach is carried out seeking that the patient can live with his disease with the least possible affectation to his daily routine.
Evolution and current results:
Larynx cancer is one of the types of cancer that have been used for laboratory trials, where the antitumor effect of Escozul™ has been proven, observing in the same a significant effect in the reduction and elimination of tumors with the use of Escozul™.
During the chemo and radiotherapy treatments, the patient's physical condition worsened, losing 20 kilograms of weight. After finishing the treatments his recovery was faster than expected, according to his doctor's opinion.
In October he underwent a repeat tomography and analysis where it was observed that the tumor lesions disappeared.
The patient is in good physical condition, with elimination of symptoms, and in the process of recovering his voice.
In the last biopsy performed in June 2016, he presented only inflammation of the vocal cord.
From that moment on Mario has been maintained in periodic check-ups with no sign of the disease to date, performing his normal activities together with his family, and with a new opportunity of life.
In this case the joint application of Escozul™, with chemo and radiotherapy eliminates the disease and also helps the patient to recover quickly.
It is important to point out that it is not possible to generalize any result with Escozul™ to avoid creating false expectations in people. Each case we receive is analyzed in order to inform the family what to expect. Each person is a completely different universe, even if they have the same disease. This writing is not a testimony but a summary of evolution where medical information is available for consultation.
To learn more about Escozul™, its effects and how to obtain it contact us at: firstname.lastname@example.org Or visit our website: www.escozul-cuba.com